Natera (NTRA) Peer Comparison
$413.31
$-1.21
(-0.29%)
As on 30-Sep-2026 16:14EDT
Market cap
$59,468 Mln
Revenue (TTM)
$2,707 Mln
P/E Ratio
--
P/B Ratio
30.9
Div. Yield
0 %
Edit
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
59,468 | 115,453 | 95,178 | 27,312 | 26,173 |
Revenue ($ Mln) |
2,707 | 415,086 | 78,013 | 11,560 | 14,348 |
Net Profit ($ Mln) |
-192.35 | 4,906.00 | 6,840.00 | 1,062.00 | 1,002.30 |
Net Margin (%) |
-7.11 | 1.18 | 8.77 | 9.19 | 6.99 |
RoE (%) |
-10.89 | 6.34 | -- | 13.77 | 11.62 |
Price to Earnings |
-- | 24.20 | 14.43 | 26.30 | 26.67 |
Price-To-Book |
30.93 | 1.47 | 291.34 | 3.63 | 3.06 |
Income Statement ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,707.08 | 415,086.00 | 78,013.00 | 11,560.00 | 14,348.00 |
|
Cost of Revenue
|
939.25 | 356,340.00 | 55,892.00 | 7,728.00 | 10,352.10 |
|
Gross Profit
|
1,495.49 | 55,362.00 | 31,374.00 | 3,523.00 | 3,732.50 |
|
Operating Expenses
|
2,057.50 | 50,458.00 | 43,457.00 | 2,197.00 | 2,378.50 |
|
Operating Profit (EBIT)
|
-289.67 | 8,288.00 | 12,073.00 | 1,635.00 | 1,617.40 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-252.70 | 5,787.00 | 9,871.00 | 1,419.00 | 1,233.70 |
|
Provision for Tax
|
-60.36 | 916.00 | 2,018.00 | 320.00 | 230.20 |
|
Profit after Tax (Net Income)
|
-192.35 | 4,906.00 | 6,840.00 | 1,062.00 | 1,002.30 |
|
Minority Interest
|
0.00 | 5.00 | -1,013.00 | -51.00 | -1.20 |
|
Consolidated Profit
|
0.00 | -1,032.00 | 3,521.00 | 488.00 | 425.80 |
Liabilities ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,821.50 | 79,702.00 | -6,575.00 | 7,516.00 | 8,606.80 |
|
Minority Interest
|
0.00 | 5.00 | -1,013.00 | -51.00 | -1.20 |
|
Non-Current Liabilities
|
282.80 | 86,828.00 | 44,528.00 | 7,252.00 | 7,784.50 |
|
Current Liabilities
|
553.20 | 87,041.00 | 19,145.00 | 1,788.00 | 2,124.60 |
|
Total Liabilities
|
2,508.04 | 261,064.00 | 60,720.00 | 16,225.00 | 18,392.70 |
Assets ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
998.55 | 178,422.00 | 45,575.00 | 14,095.00 | 14,717.40 |
|
Current Assets
|
1,658.95 | 75,346.00 | 14,956.00 | 2,844.00 | 3,814.90 |
|
Total Assets
|
2,508.04 | 261,064.00 | 60,720.00 | 16,225.00 | 18,392.70 |
|
Total Debt*
|
238.49 | 76,306.00 | 48,776.00 | 6,383.00 | 6,766.10 |
|
Net Current Assets
|
1,105.75 | -11,695.00 | -122.00 | 1,056.00 | 1,690.30 |
Cashflow ($ Mln)
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
215.30 | 10,639.00 | 12,636.00 | 1,886.00 | 1,640.50 |
|
Cash Flow from Investing Activities
|
-132.21 | -5,871.00 | -4,988.00 | -631.00 | -1,194.00 |
|
Cash from Financing Activities
|
47.46 | -4,940.00 | -8,550.00 | -1,388.00 | -1,457.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-12.58 | 1.08 | 14.79 | 7.10 | 5.63 |
|
ROE (%)
|
-10.89 | 6.34 | -612.27 | 13.77 | 11.62 |
|
ROA (%)
|
-7.19 | 1.42 | 9.05 | 5.78 | 4.84 |
|
EBIT Margin (%)
|
-9.03 | 2.14 | 15.59 | 14.24 | 10.14 |
|
Net Margin (%)
|
-7.11 | 1.18 | 8.77 | 9.19 | 6.99 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
37.82 | 7.36 | 7.31 | 9.87 | 6.41 |
|
EBIT Growth (%)
|
0.99 | -6.91 | 11.17 | 7.79 | 21.15 |
|
Net Profit Growth (%)
|
24.05 | 8.28 | 14.55 | 11.79 | 31.29 |
|
EPS Growth (%)
|
29.22 | 6.23 | 24.71 | 12.56 | 33.44 |
|
Book Value Growth (%)
|
39.14 | 1.96 | -476.58 | 4.91 | 4.18 |
Valuation Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-150.47 | 57.32 | 15.88 | 19.59 | 23.81 |
|
Price / Book Value
|
18.29 | 1.35 | -38.87 | 2.71 | 2.42 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-138.12 | 18.69 | 9.96 | 11.82 | 13.69 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.75 | -6.61 | 0.75 | 0.68 |
|
Short term debt to equity ratio
|
0.05 | 0.05 | -1.23 | 0.03 | 0.02 |
|
Current Ratio
|
3.00 | 0.87 | 0.78 | 1.59 | 1.80 |
|
Quick Ratio
|
2.85 | 0.66 | 0.69 | 1.46 | 1.53 |
|
Interest Coverage
|
-24.33 | 2.87 | 5.26 | 6.42 | 6.43 |
Operating Efficiency Ratios
| Natera (NTRA) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Quest Diagnostics (DGX) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
15.59 | 9.71 | 15.74 | 14.41 | 17.46 |
|
Asset Turnover
|
1.01 | 1.20 | 1.03 | 0.63 | 0.69 |
|
Receivable days
|
48.36 | 34.63 | 52.22 | 44.88 | 57.04 |
|
Inventory Days
|
25.50 | 19.68 | 14.00 | 9.17 | 18.37 |
|
Payable days
|
15.34 | 39.65 | 36.90 | 45.88 | 30.68 |
|
Cash Conversion Cycle
|
58.52 | 14.66 | 29.32 | 8.17 | 44.73 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
